CGS § 21a-70k. Authority of commissioner re pharmaceutical marketing firms. Regulations.

(a) The commissioner may (1) refuse to authorize the issuance or renewal of a registration to operate as a pharmaceutical marketing firm, (2) revoke, suspend or place conditions on a registration to operate as a pharmaceutical marketing firm, and (3) assess a penalty of up to one thousand dollars for each violation of any provision of section 21a-70i or 21a-70j, or take other action permitted by section 21a-11, if the applicant or holder of the registration fails to comply with the requirements set forth in section 21a-70i or 21a-70j.

(b) The commissioner may adopt regulations, in accordance with chapter 54, to implement the provisions of this section.

Short History

(P.A. 23-171, S. 6; P.A. 24-80, S. 6.)

Long History

History: P.A. 24-80 amended Subsec. (a)(3) by substituting reference to Sec. 21a-11 for reference to Sec. 21a-7(a)(7), effective May 30, 2024.